9989 — Sundrug Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesConservativeMid CapContrarian

Annual income statement for Sundrug Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	—	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	648,734	690,462	751,777	801,811	842,512
Cost of Revenue
Gross Profit	156,506	171,946	189,320	204,088	216,171
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	614,974	653,578	711,270	757,773	796,182
Operating Profit	33,760	36,884	40,507	44,038	46,330
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	34,675	37,710	41,261	43,569	45,803
Provision for Income Taxes
Net Income After Taxes	23,854	25,703	29,127	30,751	31,392
Net Income Before Extraordinary Items
Net Income	23,854	25,703	29,127	30,751	31,392
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	23,853	25,703	29,126	30,750	31,392
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	204	222	252	266	271
Dividends per Share